Pharmaceutical Companies Accused Of Colluding To Delay Generic Version Of Popular Cholesterol Drug

Pharmaceutical Companies Accused Of Colluding To Delay Generic Version Of Popular Cholesterol Drug

If you’ve got a patent-protected drug that’s bringing in more than $1 billion a year in sales, you stand to lose a significant chunk of that revenue when the patent expires and lower-cost generic versions come on the market. A California prosecutor alleges that a number of drug companies illegally colluded in a nearly decade-long “pay-for-delay” deal intended to prevent the release of a cheaper competitor to a popular cholesterol drug. [More]

The 26 Top CEOs Who Made More Than Their Companies Paid In Federal Taxes

The 26 Top CEOs Who Made More Than Their Companies Paid In Federal Taxes

Once again, it’s time for the annual Institute for Policy Studies report on which top CEOs are earning more money than the companies they work for are paying out to federal government in taxes.

[More]